In a recent study posted to the medRxiv* preprint server, researchers compared the pathophysiology of coronavirus disease 2019 (COVID-19) and bacterial sepsis-induced acute respiratory distress ...

Innate and adaptive immune cells coordinate the excessive inflammatory response known as a cytokine storm in acute respiratory distress syndrome, leading to alveolar–capillary barrier damage, ...

In a phase 2 randomised controlled trial, aspirin was well tolerated but failed to improve oxygenation index (OI) and physiological outcomes of lung injury or organ dysfunction in patients with acute ...

Acute Respiratory Distress Syndrome (ARDS) is a critical condition that arises from a severe inflammatory response within the lungs, leading to widespread alveolar damage and respiratory failure.

An initial trial suggests that a new drug, originally developed for use with cancer patients, could improve the survival of patients with acute respiratory distress syndrome (ARDS). The patients in ...

Inhaled sevoflurane significantly reduced ventilator-free days and 90-day survival versus IV propofol in moderate to severe ARDS. Inhaled volatile sedatives grew in popularity for prolonged use in ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed high lysolipid levels in those with acute respiratory distress syndrome (ARDS), which may ...

Deaths from acute respiratory distress syndrome (ARDS) and sepsis spiked in the US during the COVID pandemic, and subsequently declined, according to new data presented at the American College of ...

In a review recently published in The Lancet Respiratory Medicine journal by Osuchowski et al. (May 6 th, 2021) the currently known pathophysiology of COVID-19 is laid out to describe the mechanistic ...